EP2812027 - MICA BINDING AGENTS [Right-click to bookmark this link] | Status | The application has been refused Status updated on 03.12.2021 Database last updated on 03.04.2025 | |
Former | Examination is in progress Status updated on 11.01.2017 | Most recent event Tooltip | 03.12.2021 | Refusal of application | published on 05.01.2022 [2022/01] | Applicant(s) | For all designated states Innate Pharma 117, Avenue de Luminy 13009 Marseille / FR | [2014/51] | Inventor(s) | 01 /
BLERY, Mathieu Les Hauts de Mazargues Bt D4 50 Bd du Vaisseau F-13009 Marseille / FR | 02 /
GAUTHIER, Laurent 30 Chemin du Lancier Résidence la Sarette Bât 8 F-13008 Marseille / FR | 03 /
PERROT, Ivan Avenue Monseigneur de Belsunce Résidence "la Pinède" Bt D F-13260 Cassis / FR | 04 /
BONNAFOUS, Cécile 12 Av Gaston Bosc F-13009 Marseille / FR | [2014/51] | Representative(s) | Cabinet Becker et Associés 25, rue Louis le Grand 75002 Paris / FR | [N/P] |
Former [2014/51] | Völlmy, Lukas Innate Pharma IP Department 117, avenue de Luminy 13009 Marseille / FR | Application number, filing date | 13704064.8 | 07.02.2013 | WO2013EP52439 | Priority number, date | US201261595902P | 07.02.2012 Original published format: US 201261595902 P | US201261625841P | 18.04.2012 Original published format: US 201261625841 P | [2014/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013117647 | Date: | 15.08.2013 | Language: | EN | [2013/33] | Type: | A1 Application with search report | No.: | EP2812027 | Date: | 17.12.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 15.08.2013 takes the place of the publication of the European patent application. | [2014/51] | Search report(s) | International search report - published on: | EP | 15.08.2013 | (Supplementary) European search report - dispatched on: | EP | 24.02.2016 | Classification | IPC: | A61K39/395, A61P35/00, C07K16/28 | [2014/51] | CPC: |
C07K16/2833 (EP,RU,US);
C07K16/28 (RU,US);
A61P35/00 (EP);
G01N33/56977 (RU,US);
A61K2039/505 (EP,US);
C07K2317/24 (EP,US);
C07K2317/33 (EP,US);
C07K2317/34 (EP,US);
C07K2317/732 (EP,US);
C07K2317/734 (EP,US);
C07K2317/76 (EP,US);
C07K2317/92 (EP,US);
G01N2333/70539 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/51] | Title | German: | MICA-BINDEMITTEL | [2014/51] | English: | MICA BINDING AGENTS | [2014/51] | French: | AGENTS SE LIANT À MICA | [2014/51] | Entry into regional phase | 04.09.2014 | National basic fee paid | 04.09.2014 | Designation fee(s) paid | 04.09.2014 | Examination fee paid | Examination procedure | 04.09.2014 | Amendment by applicant (claims and/or description) | 04.09.2014 | Examination requested [2014/51] | 24.02.2016 | Despatch of a communication from the examining division to which search results under Rule 164(2) EPC are annexed (Time limit: M04) [2016/13] | 24.02.2016 | Despatch of a communication from the examining division (Time limit: M04) | 24.06.2016 | Reply to a communication from the examining division | 30.08.2016 | Despatch of a communication from the examining division (Time limit: M04) | 05.01.2017 | Reply to a communication from the examining division | 23.01.2018 | Date of oral proceedings | 13.04.2018 | Despatch of communication that the application is refused, reason: substantive examination [2022/01] | 13.04.2018 | Minutes of oral proceedings despatched | 22.07.2021 | Application refused, date of legal effect [2022/01] | Appeal following examination | 28.05.2018 | Appeal received No. T2423/18 | 24.07.2018 | Statement of grounds filed | 22.07.2021 | Result of appeal procedure: appeal of the applicant was rejected | 29.11.2021 | Despatch of the decision of the Board of Appeal | 22.07.2021 | Date of oral proceedings | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.02.2016 | Fees paid | Renewal fee | 26.02.2015 | Renewal fee patent year 03 | 26.02.2016 | Renewal fee patent year 04 | 27.02.2017 | Renewal fee patent year 05 | 27.02.2018 | Renewal fee patent year 06 | 27.02.2019 | Renewal fee patent year 07 | 27.02.2020 | Renewal fee patent year 08 | 25.02.2021 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [I]WO2008036981 (DANA FARBER CANCER RES INC [US], et al); |